The samples were labeled by prognostic leukemia subtype [‘TEL-AML1’, ‘BCR-ABL’, ‘MLL’, ‘Hyperdiploid (>50)’, ‘E2A-PBX1’, ‘T-ALL’ and ‘Other’]. This evidence concerns the gene KMT2A and leukemia.